STK17A Antikörper (C-Term)
Kurzübersicht für STK17A Antikörper (C-Term) (ABIN926874)
Target
Alle STK17A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Rind (Kuh), Kaninchen, Huhn
-
Aufreinigung
- Purified
-
Immunogen
- STK17 A antibody was raised in rabbit using the C terminal of STK17 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
STK17A Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this STK17A antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- STK17A (serine/threonine Kinase 17a (STK17A))
-
Andere Bezeichnung
- STK17A
-
Hintergrund
- STK17A belongs to the protein kinase superfamily, CAMK Ser/Thr protein kinase family, DAP kinase subfamily. It contains 1 protein kinase domain. STK17A acts as a positive regulator of apoptosis.This gene is a member of the DAP kinase-related apoptosis-inducing protein kinase family and encodes an autophosphorylated nuclear protein with a protein kinase domain. The protein has apoptosis-inducing activity. Synonyms: Polyclonal STK17A antibody, Anti-STK17A antibody, serine/threonine kinase 17a antibody, DRAK1 antibody.
Target
-